Stock of interest

November 28, 2007

Osiris Therapeutics Inc.

Shares rose $1.60, or 16 percent, to $11.84 after the Columbia-based developer of treatments using adult stem cells said its experimental drug Chondrogen eased arthritis pain in the knee.

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.